Thoracic Tumours Register
Spanish Lung Cancer Group
10,000 participants
Jul 21, 2016
OBSERVATIONAL
Conditions
Summary
Observational, multicenter study in patients with lung cancer and other thoracic tumors. The GECP, in its commitment to improve the treatment and prognosis of patients with lung cancer and other thoracic tumors, has marked the individualization of treatment according to the expression of markers predictive of response to chemotherapeutic agents and molecular inhibitors of cell proliferation as one of its primary objectives. This could significantly improve the prognosis of patients with lung cancer, and will lead to a radical change in routine clinical practice. The aim of the register is to explore all data available of all patients treated because of thoracic tumours.
Eligibility
Inclusion Criteria1
- Patients with thoracic disease, treated with an active treatment or not treated (only palliative care)
Exclusion Criteria1
- Patients with other type of tumours
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(79)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT02941458